Medical/Pharmaceuticals

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading br...

2026-03-11 23:40 5617

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc ., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the ...

2026-03-11 21:38 5137

Ulike Announces Official Partnership with the PCOS Awareness Association (PCOSAA)

NEW YORK, March 11, 2026 /PRNewswire/ -- Millions of women worldwide live with Polycystic Ovary Syndrome (PCOS), a complex hormonal condition that remains widely underdiagnosed, stigmatized, and misunderstood. Beyond its medical implications, PCOS often affects mental health, self-esteem, and dai...

2026-03-11 21:00 4152

HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together

2026-03-11 20:09 4208

GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'

* Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that a review paper comprehensively analyzing the safety...

2026-03-11 13:50 5768

Haier Biomedical Hosts European Partner Summit in Rome and Advances "In Europe, for Europe" Strategy

ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical recently convened its European Partner Summit in Rome under the theme "Advancing Together - Sharing the Future of Biomedical Innovation," which brought together 37 regional partners and industry leaders fro...

2026-03-11 12:29 6719

Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer

SUZHOU, China, March 11, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and Analytical Development Department, Production Department an...

2026-03-11 09:38 5057

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

BEIJING, March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. (" Tsingke Biotech ") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together th...

2026-03-10 22:13 5661

Registrational Phase III AMPLIFY trial: Target number of participants achieved

SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III A...

2026-03-10 21:02 6903

Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026

SHANGHAI, March 10, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its financial re...

2026-03-10 18:40 6110

Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity

-    ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses. -    ASC30 SQ depot formulation maintained weight loss for the four months following the third and final mon...

2026-03-10 18:00 7754

K-pop Singer and Actress Kim Sejeong Named Global Brand Ambassador for 'REJURAN' and 'REJURAN COSMETICS'

GANGNEUNG, South Korea, March 10, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO Jihoon Sohn) announced that singer and actress Kim Sejeong has been named the new global brand ambassador for its flagship brands REJURAN® and REJURAN® COSMETICS.

2026-03-10 16:03 6568

Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude

Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows LONDON, March 10, 2026 /PRNewswire/ -- Clarivate Plc

2026-03-10 16:00 6172

The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard

HOUSTON, March 10, 2026 /PRNewswire/ -- While exotoxins dominate discussions of bacterial infections, endotoxins—cell wall components released upon bacterial death—are equally dangerous. These endotoxins trigger hyperinflammatory responses that spiral into endotoxemia, in which bloodstream endoto...

2026-03-10 15:22 4315

Robot anxiety is highest where robots are least visible, new global study from Hexagon finds

* A global split in confidence: UK adults are most anxious (52%) vs South Korea least (29%), while high-exposure markets like China (75% of adults have seen/used robots) are also the most excited about robots' potential (81%) * The biggest concern is security, not jobs: Hacking is the top conc...

2026-03-10 15:00 4407

Codex Genetics Partners with C2N Diagnostics to Introduce the PrecivityAD2™ Blood Test in Hong Kong, Facilitating Access to Innovative Alzheimer's Disease Diagnostics

HONG KONG, March 10, 2026 /PRNewswire/ -- Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a global leader in in advanced brain health diagnostics. The partnership will introduce the Precivit...

2026-03-10 09:33 5559

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

* Webcast and conference call to be held today, Tuesday March 10 at 9:30 a.m. AEDT (Monday March 9 at 6:30 p.m. EDT). Investors can register at the following link:https://s1.c-conf.com/diamondpass/10053620-ju7y6t.html MELBOURNE, Australia...

2026-03-10 06:34 5223

Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY® in Mainland China

SHANGHAI, March 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the commercial launch of VELSIPITY® (...

2026-03-09 21:27 9045

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

News Summary: * Reduces standard testing times by 80%.1 * Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2 * Operates with fewer calibrations and superior atmosphere and temperature control. 3 SAN ANTON...

2026-03-09 21:04 4620

Court Authorizes Notice of Proposed Class Action Settlement for Farmers, Landscapers and Others Exposed to Weed Killers

ST. LOUIS, March 9, 2026 /PRNewswire/ -- Seeger Weiss LLP, Motley Rice LLC, Waters Kraus Paul & Siegel, Williams Hart & Boundas LLP, The Holland Law Firm, and Ketchmark & McCreight P.C. announce that the Circuit Court of the City of St. Louis, State of Missouri, has granted preliminary approval o...

2026-03-09 20:00 5273
1 ... 38394041424344 ... 649

Week's Top Stories